Elin Borgen

5.8k total citations
88 papers, 3.3k citations indexed

About

Elin Borgen is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elin Borgen has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 50 papers in Cancer Research and 23 papers in Molecular Biology. Recurrent topics in Elin Borgen's work include Cancer Cells and Metastasis (42 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (27 papers). Elin Borgen is often cited by papers focused on Cancer Cells and Metastasis (42 papers), Breast Cancer Treatment Studies (30 papers) and Cancer Genomics and Diagnostics (27 papers). Elin Borgen collaborates with scholars based in Norway, United States and Germany. Elin Borgen's co-authors include Bjørn Naume, Gro Wiedswang, Gunnar Kvalheim, Rolf Kåresen, Jahn M. Nesland, Marit Synnestvedt, Jahn M. Nesland, Hanne Qvist, Klaus Pantel and Ellen Schlichting and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Elin Borgen

85 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elin Borgen Norway	31	2.3k	1.8k	950	756	326	88	3.3k
Ricardo H. Álvarez United States	28	1.7k 0.8×	1.1k 0.6×	824 0.9×	558 0.7×	226 0.7×	75	2.7k
Mónica Arnedos France	25	1.6k 0.7×	1.2k 0.7×	1.4k 1.5×	1.0k 1.3×	293 0.9×	90	3.1k
John M.L. Ebos United States	23	1.6k 0.7×	1.5k 0.8×	2.3k 2.5×	711 0.9×	262 0.8×	49	4.1k
Bárbara Adamo Spain	25	1.8k 0.8×	1.4k 0.8×	1.7k 1.8×	1.0k 1.4×	308 0.9×	99	3.7k
Dimitris Mavroudis Greece	43	3.9k 1.7×	2.4k 1.3×	1.6k 1.7×	1.5k 2.0×	283 0.9×	107	5.2k
Glen Clack United Kingdom	22	2.6k 1.2×	1.3k 0.7×	798 0.8×	841 1.1×	128 0.4×	61	3.3k
Dimitrios Zardavas Belgium	21	2.1k 0.9×	1.3k 0.7×	945 1.0×	854 1.1×	231 0.7×	69	3.3k
Neesha C. Dhani Canada	25	1.9k 0.8×	966 0.5×	713 0.8×	435 0.6×	224 0.7×	113	2.6k
Christine Parkinson United Kingdom	14	1.4k 0.6×	2.4k 1.3×	1.2k 1.3×	1.3k 1.7×	623 1.9×	29	3.3k
Stacy L. Moulder United States	32	2.5k 1.1×	1.3k 0.7×	1.4k 1.5×	922 1.2×	419 1.3×	141	3.9k

Countries citing papers authored by Elin Borgen

Since Specialization

Citations

This map shows the geographic impact of Elin Borgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elin Borgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elin Borgen more than expected).

Fields of papers citing papers by Elin Borgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elin Borgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elin Borgen. The network helps show where Elin Borgen may publish in the future.

Co-authorship network of co-authors of Elin Borgen

This figure shows the co-authorship network connecting the top 25 collaborators of Elin Borgen. A scholar is included among the top collaborators of Elin Borgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elin Borgen. Elin Borgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tekpli, Xavier, Ole Christian Lingjærde, Hege G. Russnes, et al.. (2025). High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis. Communications Medicine. 5(1). 234–234.

Borgen, Elin, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, et al.. (2024). Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials. Molecular Oncology. 19(7). 2092–2108. 9 indexed citations

Gilje, Bjørnar, Andrea Gombos, Elin Borgen, et al.. (2022). 215MO ICON – a randomized phase IIb study evaluating chemotherapy combined with ipilimumab and nivolumab in metastatic hormone receptor-positive breast cancer. Annals of Oncology. 33. S636–S636. 3 indexed citations

Krüger, Kristi, Laxmi Silwal‐Pandit, Elisabeth Wik, et al.. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Scientific Reports. 11(1). 3388–3388. 16 indexed citations

Lien, Tonje G., Xavier Tekpli, Laxmi Silwal‐Pandit, et al.. (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer. International Journal of Cancer. 147(9). 2515–2525. 14 indexed citations

Hugenschmidt, Harald, Knut Jørgen Labori, Cathrine Brunborg, et al.. (2020). Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information. BMC Cancer. 20(1). 1107–1107. 4 indexed citations

Geier, Oliver, Thomas Fleischer, Øystein Garred, et al.. (2019). Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data. Cancer Research. 79(16). 4293–4304. 17 indexed citations

Davies, Helen, Sandro Morganella, Colin A. Purdie, et al.. (2017). Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency. Cancer Research. 77(18). 4755–4762. 76 indexed citations

Brunborg, Cathrine, Anne Waage, Harald Hugenschmidt, et al.. (2017). Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Annals of Surgical Oncology. 24(8). 2113–2121. 18 indexed citations

10.

Ohnstad, Hege O., Elin Borgen, Ragnhild Sørum Falk, et al.. (2017). Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up. Breast Cancer Research. 19(1). 120–120. 84 indexed citations

11.

Silwal‐Pandit, Laxmi, Hege G. Russnes, Elin Borgen, et al.. (2015). The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer. PLoS ONE. 10(10). e0139965–e0139965. 17 indexed citations

12.

Synnestvedt, Marit, Elin Borgen, Erik Wist, et al.. (2012). Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 12(1). 616–616. 18 indexed citations

13.

Janni, Wolfgang, Florian D. Vogl, Gro Wiedswang, et al.. (2011). Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis. Clinical Cancer Research. 17(9). 2967–2976. 192 indexed citations

14.

Naume, Bjørn, Xi Zhao, Marit Synnestvedt, et al.. (2007). Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Molecular Oncology. 1(2). 160–171. 113 indexed citations

15.

Fehm, Tanja, Stephan Braun, Volkmar Müller, et al.. (2006). A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer. 107(5). 885–892. 177 indexed citations

16.

Shahzidi, Susan, Živilė Lukšiené, Elin Borgen, et al.. (2005). Targeting PBR by Hexaminolevulinate-Mediated Photodynamic Therapy Induces Apoptosis through Translocation of Apoptosis-Inducing Factor in Human Leukemia Cells. Cancer Research. 65(23). 11051–11060. 71 indexed citations

17.

Naume, Bjørn, et al.. (2004). Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Cytotherapy. 6(3). 244–252. 58 indexed citations

18.

Borgen, Elin, Klaus Beiske, Sissel Trachsel, et al.. (1998). Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. The Journal of Pathology. 185(4). 427–434. 112 indexed citations

19.

Naume, Bjørn, Elin Borgen, Jahn M. Nesland, et al.. (1998). Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. International Journal of Cancer. 78(5). 556–560. 78 indexed citations

20.

Naume, Bjørn, Elin Borgen, Klaus Beiske, et al.. (1997). Immunomagnetic Techniques for the Enrichment and Detection of Isolated Breast Carcinoma Cells in Bone Marrow and Peripheral Blood. Journal of Hematotherapy. 6(2). 103–114. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact